Focal Adhesion Kinase (FAK) inhibitor (investigational, GlaxoSmithKline)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Focal Adhesion Kinase (FAK) inhibitor (investigational, GlaxoSmithKline), covering 2017-05-11 to 2017-05-11. Get the full timeline:
Most recent: Clinical Trial Update: Study of a Focal Adhesion Kinase Inhibitor in Subjects With Solid Tumors [Phase 1]